Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novartis AG (NYSE:NVS)

80.11
Delayed Data
As of May 27
 -0.03 / -0.04%
Today’s Change
69.90
Today|||52-Week Range
106.84
-6.89%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Operating ActivitiesNet Income / Starting Line1.9B1.8B1.0B2.0B
 
 
 
 
 
Depreciation1.5B1.4B1.0B1.3B
 
 
 
 
 
Total Other Cash Flow446.4M57.2M-336.0M299.9M
 
 
 
 
 
Funds From Operations3.9B3.3B1.7B3.6B
 
 
 
 
 
Funds From/For Other Operating Expenses936.2M110.1M-2.4B2.1B
 
 
 
 
 
Net Cash Flow - Operating Activities2.9B3.2B4.1B1.5B
 
 
 
 
 
 
InvestingIncrease In Investments-110.0M-36.7M-710.7M0.00
 
 
 
 
Decrease In Investments-4.9M0.00427.2M0.00
 
 
 
Capital Expenditures-574.6M-587.0M-740.8M-377.3M
 
 
 
 
 
Fixed Asset Disposal0.000.00236.6M518.5M
 
 
 
Net Assets From Acquisitions -420.8M-310.0M-24.7M-405.8M
 
 
 
 
 
Other Investing - Uses-480.5M-205.6M845.7M-521.4M
 
 
 
 
 
Other Investing - Sources-314.5M340.9M-523.2M29.4M
 
 
 
 
 
Net Cash Flow Investing-1.9B-798.5M-1.6B-756.6M
 
 
 
 
 
 
FinancingShort Term Borrowings0.00----0.00--
Long Term Borrowings-1.9B-314.5M1.9B5.5B
 
 
 
 
 
Long Term Debt Reduction0.000.00-3.1B0.00
 
 
Net Proceeds Stock Sale-80.5M0.000.000.00
 
 
Common Preferred Redeemed-542.0M-1.9B-3.6B-180.3M
 
 
 
 
 
Common Dividends----------
Cash Dividends Paid - Total-123.1M-33.3M44.7M-6.3B
 
 
 
 
 
Other Sources - Financing0.000.001.6B0.00
 
 
Other Uses - Financing-148.4M-6.8M-29.2M28.4M
 
 
 
 
 
Net Cash Flow - Financing-2.5B-2.2B-2.7B-1.0B
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash70.1M-66.7M-345.8M39.2M
 
 
 
 
 
 
Net Change In Cash-1.4B138.1M-255.3M-251.9M